| Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas RM Luque, A Ibáñez-Costa, LV Neto, GF Taboada, D Hormaechea-Agulla, ... Cancer Letters 359 (2), 299-306, 2015 | 93 | 2015 |
| Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly J Leon-Carrion, JF Martin-Rodriguez, A Madrazo-Atutxa, A Soto-Moreno, ... The Journal of Clinical Endocrinology & Metabolism 95 (9), 4367-4379, 2010 | 93 | 2010 |
| A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications RM Luque, A Ibáñez-Costa, LM López-Sánchez, L Jiménez-Reina, ... The Journal of Clinical Endocrinology & Metabolism 98 (10), 4160-4169, 2013 | 79 | 2013 |
| Octreotide and pasireotide (dis) similarly inhibit pituitary tumor cells in vitro A Ibáñez-Costa, E Rivero-Cortés, MC Vázquez-Borrego, MD Gahete, ... J Endocrinol 231 (2), 135-145, 2016 | 74 | 2016 |
| In1-ghrelin splicing variant is overexpressed in pituitary adenomas and increases their aggressive features A Ibánez-Costa, MD Gahete, E Rivero-Cortés, D Rincón-Fernández, ... Scientific reports 5 (1), 8714, 2015 | 73 | 2015 |
| Neurocognitive function in acromegaly after surgical resection of GH-secreting adenoma versus naïve acromegaly JF Martín-Rodríguez, A Madrazo-Atutxa, E Venegas-Moreno, ... PLoS One 8 (4), e60041, 2013 | 54 | 2013 |
| Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly E Venegas‐Moreno, MC Vazquez‐Borrego, E Dios, N Gros‐Herguido, ... Journal of Cellular and Molecular Medicine 22 (3), 1640-1649, 2018 | 53 | 2018 |
| E‐cadherin expression is associated with somatostatin analogue response in acromegaly E Venegas‐Moreno, A Flores‐Martinez, E Dios, MC Vazquez‐Borrego, ... Journal of cellular and molecular medicine 23 (5), 3088-3096, 2019 | 42 | 2019 |
| A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors MC Vázquez-Borrego, V Gupta, A Ibáñez-Costa, MD Gahete, ... Clinical Cancer Research 26 (4), 957-969, 2020 | 40 | 2020 |
| Pacientes en riesgo de desnutrición en asistencia primaria. Estudio sociosanitario EV Moreno, AS Moreno, JLP Cunill, PG Peris, ML Sanz, AMP Mercé, ... Nutr. Hosp 16 (1), 1-6, 2001 | 38 | 2001 |
| Biguanides exert antitumoral actions in pituitary tumor cells through AMPK-dependent and-independent mechanisms MC Vázquez-Borrego, AC Fuentes-Fayos, AD Herrera-Martínez, ... The Journal of Clinical Endocrinology & Metabolism 104 (8), 3501-3513, 2019 | 36 | 2019 |
| Splicing machinery is dysregulated in pituitary neuroendocrine tumors and is associated with aggressiveness features MC Vázquez-Borrego, AC Fuentes-Fayos, E Venegas-Moreno, ... Cancers 11 (10), 1439, 2019 | 32 | 2019 |
| Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study M Puig-Domingo, A Soto, E Venegas, R Vilchez, C Blanco, F Cordido, ... Endocrinología y Nutrición (English Edition) 63 (8), 397-408, 2016 | 29 | 2016 |
| AIP and MEN1 mutations and AIP immunohistochemistry in pituitary adenomas in a tertiary referral center AF Daly, DA Cano, E Venegas-Moreno, P Petrossians, E Dios, ... Endocrine connections 8 (4), 338-348, 2019 | 27 | 2019 |
| BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas A Ibáñez-Costa, LM López-Sánchez, MD Gahete, E Rivero-Cortés, ... Scientific reports 7 (1), 1-14, 2017 | 27 | 2017 |
| A new generation somatostatin-dopamine analogue exerts potent antitumoral actions on pituitary neuroendocrine tumor cells MC Vázquez-Borrego, MA Gálvez-Moreno, AC Fuentes-Fayos, ... Neuroendocrinology 110 (1-2), 70-82, 2020 | 22 | 2020 |
| The Molecular Registry of Pituitary Adenomas (REMAH): A bet by Spanish Endocrinology for the future of individualized medicine and translational research RM Luque, A Ibáñez-Costa, L Sánchez-Tejada, E Rivero-Cortés, ... Endocrinología y Nutrición (English Edition) 63 (6), 274-284, 2016 | 18 | 2016 |
| Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism A León-Justel, MA Mangas, RI Fontán, JC Luque, EV Moreno, AM Atutxa, ... Clinica Chimica Acta 412 (23-24), 2248-2253, 2011 | 18 | 2011 |
| Atención sanitaria urgente y demanda social: reflexiones sobre la elección de un modelo de respuesta E Moreno Emergencias 7 (3), 108-115, 1995 | 18 | 1995 |
| Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease A Leal-Cerro, JF Martín-Rodríguez, A Ibáñez-Costa, A Madrazo-Atutxa, ... Endocrinología y Nutrición (English Edition) 61 (2), 69-76, 2014 | 17 | 2014 |
